Stephen M. Ansell, MD. PhD. and Radhakrishnan Ramchandren, MD discuss the Zuma 1 trial on pretreated large cell lymphoma. The CAR T-cell treatment showed a 60% to 70% response rates …
Investigating CAR T-Cell Therapy in Lymphoma Read More
Dr. Cohen describes what to expect in 2018 in the area of CAR T cell therapy, one of the most exciting new modalities for the treatment of multiple myeloma.
CAR-T cell therapy and what to look for in 2018 Read More
CAR T-Cell Therapy: A Viable Option? Chimeric antigen receptor (CAR) T-cell therapy is the first form of gene therapy approved in the U.S. CAR T-cell therapy works with the patient’s …
CAR T-Cell Therapy HCP Guide – CAR T-Cell Therapy’s Effect on the Healthcare System Read More
December 11, 2017 (HealthDay News) Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy and …
ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas Read More
T-Cell Receptor Therapy: The Next Generation T cells are one type of lymphocyte important for the immune system to function properly. As with CAR T-cell therapy effect on hematologic cancers, …
CAR T-Cell Therapy HCP Guide – The Next Generation for T-Cell Receptor Therapy Read More